Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (Alliance) N9831

Amylou C. Dueck, Monica M. Reinholz, Xochiquetzal J. Geiger, Kathleen Tenner, Karla Ballman, Robert B. Jenkins, Darren Riehle, Beiyun Chen, Ann E. McCullough, Nancy E. Davidson, Silvana Martino, George W. Sledge, Peter A. Kaufman, Leila A. Kutteh, Julie Gralow, Lyndsay N. Harris, James N. Ingle, Wilma L. Lingle, Edith A. Perez

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Impact of c-MYC protein expression on outcome of patients with early-stage HER2<sup>+</sup> breast cancer treated with adjuvant trastuzumab NCCTG (Alliance) N9831'. Together they form a unique fingerprint.

Medicine & Life Sciences